Dr. Clark, 45, admitted that from 2016 through 2020, she attempted to conceal from patients and the FDA that she was using unapproved and unlicensed botox injections and cosmetic filler devices, the Justice Department said. She also admitted to selling them to patients as Botox and Juvederm, which are both FDA-approved.
Dr. Clark’s practice landed more than $1 million in connection with misbranded and adulterated product sales, the Justice Department said.
Sentencing is set for April 7.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
